Tali Eviatar

1.1k total citations
21 papers, 130 citations indexed

About

Tali Eviatar is a scholar working on Rheumatology, Infectious Diseases and Hematology. According to data from OpenAlex, Tali Eviatar has authored 21 papers receiving a total of 130 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Rheumatology, 5 papers in Infectious Diseases and 5 papers in Hematology. Recurrent topics in Tali Eviatar's work include Systemic Lupus Erythematosus Research (6 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and Autoimmune and Inflammatory Disorders Research (4 papers). Tali Eviatar is often cited by papers focused on Systemic Lupus Erythematosus Research (6 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and Autoimmune and Inflammatory Disorders Research (4 papers). Tali Eviatar collaborates with scholars based in Israel, Switzerland and United Kingdom. Tali Eviatar's co-authors include Ophir Freund, Gil Bornstein, Yossi Rosman, Michal Shani, Ehud Grossman, Chen Hoffman, Michael Thaler, Nathan Keller, Shlomo Vinker and Michael Zisapel and has published in prestigious journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and Clinical & Experimental Immunology.

In The Last Decade

Tali Eviatar

19 papers receiving 127 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tali Eviatar Israel 7 38 35 29 29 22 21 130
Ching J. Chen United States 11 8 0.2× 23 0.7× 16 0.6× 16 0.6× 13 0.6× 14 294
John F. Paschal United States 9 134 3.5× 10 0.3× 18 0.6× 54 1.9× 5 0.2× 9 415
James McIntosh United States 6 22 0.6× 4 0.1× 3 0.1× 8 0.3× 13 0.6× 10 130
António Figueiredo Portugal 6 10 0.3× 8 0.2× 39 1.3× 11 0.5× 28 133
P. Bélénotti France 5 25 0.7× 4 0.1× 4 0.1× 37 1.3× 22 1.0× 19 139
Paul H. Kalina United States 8 76 2.0× 1 0.0× 10 0.3× 46 1.6× 26 1.2× 11 271
Seyed Reza Najafizadeh Iran 8 106 2.8× 13 0.4× 19 0.7× 4 0.2× 23 186
A. Weinberger Israel 6 13 0.3× 1 0.0× 4 0.1× 22 0.8× 9 0.4× 9 141
L. Fuertes Spain 7 12 0.3× 4 0.1× 32 1.1× 21 1.0× 32 131
Mohamed Ben‐Gashir Qatar 6 24 0.6× 3 0.1× 14 0.5× 10 0.5× 13 381

Countries citing papers authored by Tali Eviatar

Since Specialization
Citations

This map shows the geographic impact of Tali Eviatar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tali Eviatar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tali Eviatar more than expected).

Fields of papers citing papers by Tali Eviatar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tali Eviatar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tali Eviatar. The network helps show where Tali Eviatar may publish in the future.

Co-authorship network of co-authors of Tali Eviatar

This figure shows the co-authorship network connecting the top 25 collaborators of Tali Eviatar. A scholar is included among the top collaborators of Tali Eviatar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tali Eviatar. Tali Eviatar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Freund, Ophir, Tali Eviatar, Roni Meidan, et al.. (2025). Dynamics of interstitial lung disease following immunosuppressive treatment differ between antisynthetase syndrome and systemic sclerosis. Therapeutic Advances in Respiratory Disease. 19. 2703916224–2703916224.
2.
Leibovitch, Igal, et al.. (2024). Ocular and orbital manifestations in VEXAS syndrome. Eye. 38(9). 1748–1754. 11 indexed citations
3.
Gertel, Smadar, Ari Polachek, Tali Eviatar, Ori Elkayam, & Victoria Furer. (2024). A novel inhibitory pathway of synovial inflammation exerted by glucocorticoids and tumour necrosis factor inhibitors via lymphocyte activation gene-3 up-regulation: an ex vivo study. Lara D. Veeken. 64(4). 1689–1697. 2 indexed citations
4.
Eviatar, Tali, et al.. (2024). Cellular immune response to the anti-SARS-CoV-2 BNT162b2 mRNA vaccine in pediatric autoimmune inflammatory rheumatic disease patients and controls. Clinical & Experimental Immunology. 217(2). 167–172. 1 indexed citations
5.
Eviatar, Tali, et al.. (2024). Real-world treatment patterns in patients with systemic lupus erythematosus: associations with comorbidities and damage. Lupus Science & Medicine. 11(2). e001266–e001266. 2 indexed citations
6.
Zisapel, Michael, Jeremy Molad, Hen Hallevi, et al.. (2024). Case report: Cerebral sinus vein thrombosis in VEXAS syndrome. Frontiers in Medicine. 11. 1377768–1377768. 5 indexed citations
7.
Eviatar, Tali, Ori Elkayam, Yanai Ben‐Gal, et al.. (2023). Heart Valve Surgery in Antiphospholipid Syndrome Patients—Morbidity and Mortality. Life. 13(4). 891–891. 3 indexed citations
8.
Meidan, Roni, Ofir Elalouf, Riva Tauman, et al.. (2023). Systemic Lupus Erythematous and Obstructive Sleep Apnea: A Possible Association. Life. 13(3). 697–697. 6 indexed citations
9.
10.
11.
Freund, Ophir, Tali Eviatar, & Gil Bornstein. (2022). Concurrent myopathy and inflammatory cardiac disease in COVID-19 patients: a case series and literature review. Rheumatology International. 42(5). 905–912. 17 indexed citations
12.
Eviatar, Tali, Devy Zisman, Omer Gendelman, et al.. (2022). Secukinumab real world drug retention compared to TNF-alpha inhibitors in psoriatic arthritis. Clinical and Experimental Rheumatology. 40(1). 15–23. 7 indexed citations
13.
Meidan, Rina, Daphna Paran, Riva Tauman, et al.. (2021). AB0312 INCREASED PREVALENCE OF OBSTRUCTIVE SLEEP APNEA IN INDIVIDUALS WITH SYSTEMIC LUPUS ERYTHEMATOSUS. Annals of the Rheumatic Diseases. 80. 1181–1182. 1 indexed citations
14.
Eviatar, Tali, Ofir Elalouf, Victoria Furer, et al.. (2021). Prevalence of COVID‐19 and seroprevalence to SARS‐CoV‐2 in a rheumatologic patient population from a tertiary referral clinic in Israel. Internal Medicine Journal. 51(5). 682–690. 3 indexed citations
15.
Eviatar, Tali, David Levartovsky, Victoria Furer, et al.. (2021). POS1206 SEROPREVALENCE OF SARS-CoV-2 ANTIBODIES IN AUTOIMMUNE INFLAMMATORY RHEUMATOLOGIC PATIENTS. Annals of the Rheumatic Diseases. 80. 885–886. 1 indexed citations
16.
Eviatar, Tali, Victoria Furer, Ari Polachek, et al.. (2021). Seroprevalence of SARS-CoV-2 antibodies in patients with autoimmune inflammatory rheumatic diseases. Clinical and Experimental Rheumatology. 40(7). 1299–1305. 2 indexed citations
17.
Eviatar, Tali & Ori Elkayam. (2019). Paraneoplastic Dactylitis Leading to the Diagnosis of Ovarian Cancer.. PubMed. 21(5). 354–355. 1 indexed citations
18.
Shani, Michal, et al.. (2018). Diabetic Retinopathy –Incidence And Risk Factors In A Community Setting- A Longitudinal Study. Scandinavian Journal of Primary Health Care. 36(3). 237–241. 21 indexed citations
19.
Eviatar, Tali, et al.. (2013). PW01-010 – The effect of pregnancy on disease course in FMF. Pediatric Rheumatology. 11(S1). 2 indexed citations
20.
Rosman, Yossi, Ehud Grossman, Nathan Keller, et al.. (2013). Nocardiosis: A 15-year experience in a tertiary medical center in Israel. European Journal of Internal Medicine. 24(6). 552–557. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ching J. Chen Breakdown of academic impact, for papers by John F. Paschal Breakdown of academic impact, for papers by James McIntosh Breakdown of academic impact, for papers by António Figueiredo Breakdown of academic impact, for papers by P. Bélénotti Breakdown of academic impact, for papers by Paul H. Kalina Breakdown of academic impact, for papers by Seyed Reza Najafizadeh Breakdown of academic impact, for papers by A. Weinberger Breakdown of academic impact, for papers by L. Fuertes Breakdown of academic impact, for papers by Mohamed Ben‐Gashir
Rankless by CCL
2026